Altium Capital Management LP Vallon Pharmaceuticals, Inc. Transaction History

Altium Capital Management LP

  • $283 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$3.85 - $9.68 $621,544 - $1.56 Million
-161,440 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$3.66 - $5.83 $507,129 - $807,804
-138,560 Reduced 46.19%
161,440 $878,000
Q1 2021

May 06, 2021
BUY
$4.32 - $7.83 $1.3 Million - $2.35 Million
300,000 New
300,000 $1.39 Million

About Vallon Pharmaceuticals, Inc.

VLON Quotes by TradingView
  • Ticker VLON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,512,800
  • Description
  • Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the ...
More about VLON
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email